MTNB
AMEX · Biotechnology
Matinas Biopharma Holdings I
$0.59
+0.02 (+3.15%)
Open$0.56
Previous Close$0.57
Day High$0.62
Day Low$0.56
52W High$41.06
52W Low$27.31
Volume—
Avg Volume414.4K
Market Cap3.78M
P/E Ratio—
EPS$-1.75
SectorBiotechnology
Analyst Ratings
Strong Sell
7 analysts
Price Target
+6,566.1% upside
Current
$0.59
$0.59
Target
$39.33
$39.33
$22.47
$39.33 avg
$48.65
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 545.4K | 506.2K | 440.2K |
| Net Income | -151,735 | -126,413 | -142,621 |
| Profit Margin | -27.8% | -25.0% | -32.4% |
| EBITDA | -193,711 | -167,268 | -163,365 |
| Free Cash Flow | -191,504 | -185,587 | -103,932 |
| Rev Growth | -0.1% | +13.2% | +21.4% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |